VIVAX
Price
$66.44
Change
+$0.77 (+1.17%)
Updated
Dec 20 closing price
VVIAX
Price
$66.44
Change
+$0.78 (+1.19%)
Updated
Dec 20 closing price
Ad is loading...

VIVAX vs VVIAX

Header iconVIVAX vs VVIAX Comparison
Open Charts VIVAX vs VVIAXBanner chart's image
Vanguard Value Index I
Price$66.44
Change+$0.77 (+1.17%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$66.44
Change+$0.78 (+1.19%)
VolumeN/A
CapitalizationN/A
VIVAX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VIVAX vs. VVIAX commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VIVAX is a Hold and VVIAX is a Hold.

FUNDAMENTALS
Fundamentals
VIVAX (195B) and VVIAX (195B) have equal amount of cash in the bank . VVIAX (2.36) and VIVAX (2.25) have matching dividends . VIVAX was incepted earlier than VVIAX: VIVAX (32 years) vs VVIAX (24 years). VIVAX (10.00) and VVIAX (10.00) have comparable annual turnover. VIVAX (3000) and VVIAX (3000) have matching initial minimum investment requirements. VVIAX (15.21) and VIVAX (15.15) have marching annual gain over last year. VVIAX (41.36) and VIVAX (41.35) have equivalent 5 years return.
VIVAXVVIAXVIVAX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence32 years24 years-
Gain YTD14.00014.042100%
Front LoadN/AN/A-
Min. Initial Investment30003000100%
Min. Initial Investment IRAN/AN/A-
Net Assets195B195B100%
Annual Yield % from dividends2.252.3695%
Returns for 1 year15.1515.21100%
Returns for 3 years18.2518.26100%
Returns for 5 years41.3541.36100%
Returns for 10 years99.5399.61100%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDTC2.560.12
+4.92%
CytoMed Therapeutics Limited
AQN4.390.08
+1.86%
Algonquin Power & Utilities Corp
BIIB146.47-0.92
-0.62%
Biogen
DOLE13.70-0.11
-0.80%
Dole plc
BNTC11.52-0.64
-5.30%
Benitec Biopharma